Par Drugs and Chemicals Limited (NSE:PAR)
99.00
-1.51 (-1.50%)
Jun 6, 2025, 3:29 PM IST
Par Drugs and Chemicals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 133.58 | 145.01 | 113.34 | 92.13 | 116.11 | Upgrade
|
Depreciation & Amortization | 36.47 | 34.36 | 32.33 | 32.81 | 28.19 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -0.08 | -1.43 | - | -19.86 | Upgrade
|
Other Operating Activities | -10.14 | 3.17 | -5.84 | 5.46 | -0.21 | Upgrade
|
Change in Accounts Receivable | -30 | 32.55 | 14.98 | -60.16 | -0.83 | Upgrade
|
Change in Inventory | -19.29 | 12.02 | -6.66 | -17.16 | -0.8 | Upgrade
|
Change in Accounts Payable | 55.35 | -27.35 | -25.7 | 39.44 | 5.13 | Upgrade
|
Change in Other Net Operating Assets | -4.36 | 2.82 | 12.75 | -16.38 | -6.89 | Upgrade
|
Operating Cash Flow | 161.6 | 202.49 | 133.77 | 76.15 | 120.85 | Upgrade
|
Operating Cash Flow Growth | -20.19% | 51.37% | 75.66% | -36.99% | 57.13% | Upgrade
|
Capital Expenditures | -12.27 | -60.8 | -76.34 | -32.02 | -50.49 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.12 | 2 | - | 49.21 | Upgrade
|
Investment in Securities | -250.58 | -0.02 | - | - | 0.47 | Upgrade
|
Other Investing Activities | 10.48 | 2.32 | 0.96 | 1.84 | 1.33 | Upgrade
|
Investing Cash Flow | -252.37 | -58.38 | -73.38 | -30.18 | 0.51 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 32.48 | Upgrade
|
Total Debt Issued | - | - | - | - | 32.48 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -32.4 | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | -43.9 | -2.27 | Upgrade
|
Total Debt Repaid | - | - | - | -76.3 | -2.27 | Upgrade
|
Net Debt Issued (Repaid) | - | - | - | -76.3 | 30.21 | Upgrade
|
Common Dividends Paid | - | - | - | -15.3 | -7.69 | Upgrade
|
Dividends Paid | - | - | - | -15.3 | -7.69 | Upgrade
|
Other Financing Activities | - | - | -0.02 | -3.9 | -6.03 | Upgrade
|
Financing Cash Flow | - | - | -0.02 | -95.5 | 16.49 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0.07 | - | Upgrade
|
Net Cash Flow | -90.77 | 144.11 | 60.37 | -49.6 | 137.85 | Upgrade
|
Free Cash Flow | 149.34 | 141.69 | 57.43 | 44.13 | 70.36 | Upgrade
|
Free Cash Flow Growth | 5.40% | 146.69% | 30.15% | -37.28% | 14.73% | Upgrade
|
Free Cash Flow Margin | 14.79% | 14.81% | 6.00% | 5.88% | 11.58% | Upgrade
|
Free Cash Flow Per Share | 12.14 | 11.52 | 4.67 | 3.59 | 5.72 | Upgrade
|
Cash Interest Paid | - | - | 0.02 | 3.7 | 6.03 | Upgrade
|
Cash Income Tax Paid | 45.17 | 43.6 | 42.63 | 31.24 | 35.95 | Upgrade
|
Levered Free Cash Flow | 120.93 | 121.43 | 42.52 | 34.24 | 50.55 | Upgrade
|
Unlevered Free Cash Flow | 121.44 | 121.43 | 42.54 | 36.59 | 54.32 | Upgrade
|
Change in Net Working Capital | 1.85 | -26.74 | 7.05 | 45.28 | 5.84 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.